Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

被引:17
|
作者
Ali, Monadil H. [1 ,2 ]
Alrasheedy, Alian A. [3 ]
Hassali, Mohamed Azmi [1 ]
Kibuule, Dan [4 ]
Godman, Brian [1 ,5 ,6 ,7 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden 11800, Malaysia
[2] Northern Border Univ, Coll Pharm, Dept Clin Pharm, Rafha 91911, Saudi Arabia
[3] Qassim Univ, Unaizah Coll Pharm, Qasim 51911, Saudi Arabia
[4] Univ Namibia, Fac Hlth Sci, Sch Pharm, 340 Mandume Ndemufayo Ave Pioneers Pk, Windhoek 13301, Namibia
[5] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, ZA-0204 Pretoria, South Africa
来源
ANTIBIOTICS-BASEL | 2019年 / 8卷 / 03期
关键词
MDR-TB; Predictors; Sudan; Tuberculosis; RISK-FACTORS; DRUG-RESISTANCE; PATTERN; STATE;
D O I
10.3390/antibiotics8030090
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] New drug for multidrug-resistant (MDR) tuberculosis (TB)
    Arya, Vivek
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 253 - 253
  • [32] Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
    Al-Mutairi, Noura M.
    Ahmad, Suhail
    Mokaddas, Eiman M.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2019, 24 (01)
  • [33] Outcome of multidrug-resistant tuberculosis (MDR-TB): A comparison between inpatient and outpatient therapy.
    Alonso, P
    Narita, M
    Lausardo, M
    Hollender, E
    Ashkin, D
    Pitchenik, AE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A551 - A551
  • [34] Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
    Ateba-Ngoa, U.
    Edoa, J. R.
    Adegbite, B. R.
    Rossatanga, E. G.
    Madiou, D.
    Mfoumbi, A.
    Mevyann, C.
    Agbo, P. Achimi
    Mahoumbou, J.
    Gould, S.
    Lell, B.
    Adegnika, A. A.
    Koehler, C.
    Kremsner, P. G.
    Massinga-Loembe, M.
    Alabi, A.
    Grobusch, M. P.
    INFECTION, 2019, 47 (05) : 811 - 816
  • [35] The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
    Brigaste M.B.T.
    Teh L.A.
    Psychological Studies, 2018, 63 (1) : 9 - 18
  • [36] Acute Respiratory Failure and Sepsis Due to Multidrug-Resistant Tuberculosis (MDR-TB) in a Pregnant Midwife
    Colunche, C.
    Angeles, B.
    Maguina, M.
    Yachachin, J.
    Chavez, W.
    Diaz, J.
    Accinelli, R.
    Valdivia, E.
    Tafur, K.
    Morello, E.
    Chancafe, R.
    Cok, J.
    Lovaton, N.
    Gayoso, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China
    Liu, Y.
    Sun, Y.
    Zhang, X.
    Zhang, Z.
    Xing, Q.
    Ren, W.
    Yao, C.
    Yu, J.
    Ding, B.
    Wang, S.
    Li, C.
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [38] Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
    Noura M. Al-Mutairi
    Suhail Ahmad
    Eiman M. Mokaddas
    European Journal of Medical Research, 24
  • [39] Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
    Sturdy, Ann
    Goodman, Anna
    Jose, Ricardo J.
    Loyse, Angela
    O'Donoghue, Marie
    Kon, Onn Min
    Dedicoat, Martin J.
    Harrison, Thomas S.
    John, Laurence
    Lipman, Marc
    Cooke, Graham S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1815 - 1820
  • [40] Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field
    U. Ateba-Ngoa
    J. R. Edoa
    B. R. Adegbite
    E. G. Rossatanga
    D. Madiou
    A. Mfoumbi
    C. Mevyann
    P. Achimi Agbo
    J. Mahoumbou
    S. Gould
    B. Lell
    A. A. Adegnika
    C. Köhler
    P. G. Kremsner
    M. Massinga-Loembe
    A. Alabi
    M. P. Grobusch
    Infection, 2019, 47 : 811 - 816